Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
Clinical trial NCT00711269 · COMPLETED
Trial details
- NCT number
- NCT00711269
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-27
- Primary completion
- 2010-04-27
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.